HOME >> BIOLOGY >> NEWS
Pitt Professor awarded competitive Sloan Research Fellowship

PITTSBURGH--Marc Sommer, assistant professor in the University of Pittsburgh's Department of Neuroscience, has received an Alfred P. Sloan Research Fellowship, a competitive award given to the "very best" scientists at an early stage in their faculty careers.

The two-year, $45,000 award will fund Sommer's research into how brain areas communicate with each other during normal behaviors, and how this communication breaks down in such mental disorders as schizophrenia. Sommer studies the signals sent from deep brain structures, such as the cerebellum, to the prefrontal cortex, considered to be the seat of cognitive abilities.

Sommer is investigating how this input to prefrontal cortex normally influences how we see, move, and make decisions, and how the flow of information is altered in an animal model of schizophrenia. To do this, he "eavesdrops" on single nerve cells using fine electrodes with microscopic tips, and also determines the inputs and outputs of the cells.

"Marc's approach, the creativity he brings to what he does, is quite unusual for a starting-out scientist," said Alan Sved, chair of Pitt's neuroscience department. "There's no question in my mind and those of the faculty in the department that Marc is the most outstanding young scientist now working in the area of sensorimotor processing in primate cortex."

The Alfred P. Sloan Foundation, a philanthropic nonprofit institution, was established in 1934 by Alfred Pritchard Sloan Jr., then-president and chief executive officer of the General Motors Corporation. The Sloan Research Fellowships were established in 1955 to provide support and recognition to early-career scientists and scholars, often in their first appointments to university faculties, who were endeavoring to set up laboratories and establish their independent research projects with little or no outside support. Currently, a total of 116 fellowships are awarded annually in seven fields: chemistry, computational
'"/>

Contact: Karen Hoffmann
klh52@pitt.edu
412-624-4356
University of Pittsburgh
5-May-2005


Page: 1 2

Related biology news :

1. UCSB Assistant Professor Patrick Daugherty wins Young Investigator Award from ACS
2. Krber Prize to ETH Zurich Professor Seeberger
3. Professors to develop hand-held pathogen testing device
4. Professor analyzes nuclear receptors in bee genome
5. Professor earns carbon sequestration research grant
6. Tufts David Walt named Howard Hughes Medical Institute Professor
7. Richard Zare named Howard Hughes Medical Institute Professor
8. Stevens Professor Alan Blumberg to speak at New York Public Library
9. Yale Public Health Professor elected fellow of the American Statistical Association
10. Allergies affect 15 million people in UK, says Professor
11. Jan Lwe awarded 2007 EMBO Gold Medal

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Pitt Professor awarded competitive Sloan Research Fellowship

(Date:10/15/2014)... increased resistance to bacterial pneumonia in female mice to ... , Females are naturally more resistant to respiratory infections ... shown that increased resistance to bacterial pneumonia in female ... 3 (NOS3). They also show that this enzyme is ... hormone estrogen. , The team, lead by Professor Lester ...
(Date:10/14/2014)... Cancer Research shows SIRT6—a protein known to inhibit ... development of skin cancers by turning on an enzyme ... cells. , Previously considered protective, SIRT6 is part of ... regulate genomic stability and prevent some of the genetic ... which can lead to cancer. This study, in the ...
(Date:10/14/2014)... October 14, 2014 – High doses of fish oil supplements, ... a common type of irregular heartbeat in which the heart ... results of the AFFORD trial led by the Montreal Heart ... College of Cardiology on October 7th. , For the ... therapy were randomly assigned to 4 grams of fish oil ...
Breaking Biology News(10 mins):Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer 2
(Date:10/22/2014)... 21, 2014 Shimadzu Scientific Instruments introduces ... tool for the pain management and clinical markets. The ... and review by allowing users to highlight and review ... , QuantAnalytics allows analysts to filter results by group ... processing by eliminating the need to sift through analytes ...
(Date:10/22/2014)... Hill, SC (PRWEB) October 22, 2014 ... expansion of its cardiovascular pharmacogenetics menu, which enables ... patient outcomes. With PCLS’s evidence-based results, healthcare ... needs and optimize their therapy, while minimizing risks ... In the U.S., according to the FDA [1] ...
(Date:10/22/2014)... 2014 Research and Markets  has announced ... Material, by Application, Geography - Global Analysis and Forecast ... Organic electronics, also called as polymer electronics ... which deals with small conductive molecules and electrically conductive ... and polymers are carbon based, made using synthetic strategies ...
(Date:10/20/2014)... , Oct. 20, 2014 Asterias ... the Company has signed a Notice of Grant ... Medicine (CIRM), effective October 1, 2014.  The NGA ... payments and the release of additional grant funds ... grant award for clinical development of Asterias, product, ...
Breaking Biology Technology:Shimadzu Releases QuantAnalytics Open Access LCMS Software Package for Clinical Applications 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 3Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 2Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4
Cached News: